BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29139383)

  • 41. Super-speedy sequencing puts genomic diagnosis in the fast lane.
    Eisenstein M
    Nature; 2024 Feb; 626(8000):915-917. PubMed ID: 38374432
    [No Abstract]   [Full Text] [Related]  

  • 42. Validation for clinical use of, and initial clinical experience with, a novel approach to population-based carrier screening using high-throughput, next-generation DNA sequencing.
    Hallam S; Nelson H; Greger V; Perreault-Micale C; Davie J; Faulkner N; Neitzel D; Casey K; Umbarger MA; Chennagiri N; Kramer AC; Porreca GJ; Kennedy CJ
    J Mol Diagn; 2014 Mar; 16(2):180-9. PubMed ID: 24374108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improving post-natal detection of mitochondrial DNA mutations.
    Barcia G; Assouline Z; Magen M; Pennisi A; Rötig A; Munnich A; Bonnefont JP; Steffann J
    Expert Rev Mol Diagn; 2020 Oct; 20(10):1003-1008. PubMed ID: 32902337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A customized scaffolds approach for the detection and phasing of complex variants by next-generation sequencing.
    Zeng Q; Leach NT; Zhou Z; Zhu H; Smith JA; Rosenblum LS; Kenyon A; Heim RA; Eisenberg M; Letovsky S; Okamoto PM
    Sci Rep; 2020 Sep; 10(1):15060. PubMed ID: 32929119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular Analysis of Circulating Cell-Free DNA from Lung Cancer Patients in Routine Laboratory Practice: A Cross-Platform Comparison of Three Different Molecular Methods for Mutation Detection.
    Bartels S; Persing S; Hasemeier B; Schipper E; Kreipe H; Lehmann U
    J Mol Diagn; 2017 Sep; 19(5):722-732. PubMed ID: 28723342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Come together, right now!
    Baxter K; Terry SF
    Genet Test Mol Biomarkers; 2011 Oct; 15(10):665-6. PubMed ID: 21992487
    [No Abstract]   [Full Text] [Related]  

  • 47. Is it research or is it clinical? Revisiting an old frontier through the lens of next-generation sequencing technologies.
    Bertier G; Cambon-Thomsen A; Joly Y
    Eur J Med Genet; 2018 Oct; 61(10):634-641. PubMed ID: 29704685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Genetic Approach: Next-Generation Sequencing-Based Diagnosis of Congenital and Infantile Myopathies/Muscle Dystrophies.
    Kress W; Rost S; Kolokotronis K; Meng G; Pluta N; Müller-Reible C
    Neuropediatrics; 2017 Aug; 48(4):242-246. PubMed ID: 28482373
    [No Abstract]   [Full Text] [Related]  

  • 49. Deep Mutational Scanning: A Highly Parallel Method to Measure the Effects of Mutation on Protein Function.
    Starita LM; Fields S
    Cold Spring Harb Protoc; 2015 Aug; 2015(8):711-4. PubMed ID: 26240414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Forty-five years to diagnosis.
    Erdmann J; Schunkert H
    Neuromuscul Disord; 2013 Jun; 23(6):503-5. PubMed ID: 23623466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Confirming Variants in Next-Generation Sequencing Panel Testing by Sanger Sequencing.
    Baudhuin LM; Lagerstedt SA; Klee EW; Fadra N; Oglesbee D; Ferber MJ
    J Mol Diagn; 2015 Jul; 17(4):456-61. PubMed ID: 25960255
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Application of targeted capture technology and next generation sequencing in molecular diagnosis of inherited myopathy].
    Fu X; Liu A; Yang H; Wei C; Ding J; Wang S; Wang J; Yuan Y; Jiang Y; Xiong H
    Zhonghua Er Ke Za Zhi; 2015 Oct; 53(10):741-6. PubMed ID: 26758109
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Scientists Seek Uniform Reference Standards for Sequencing DNA of Cancers.
    Jenks S
    J Natl Cancer Inst; 2017 Jun; 109(6):. PubMed ID: 30053243
    [No Abstract]   [Full Text] [Related]  

  • 54. [Diagnosis for skeletal muscle disorders using next-generation sequencing.].
    Mitsuhashi S
    Clin Calcium; 2017; 27(3):401-408. PubMed ID: 28232655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Should genetic testing go digital?
    VanInsberghe M; Heyries KA; Hansen CL
    Expert Rev Mol Diagn; 2012 Mar; 12(2):111-4. PubMed ID: 22369369
    [No Abstract]   [Full Text] [Related]  

  • 56. High-throughput approaches for the genetic diagnosis of retinal dystrophies.
    Pomares E; Marfany G; Gonzàlez-Duarte R
    Adv Exp Med Biol; 2012; 723():329-35. PubMed ID: 22183350
    [No Abstract]   [Full Text] [Related]  

  • 57. Making the Leap from Research Laboratory to Clinic: Challenges and Opportunities for Next-Generation Sequencing in Infectious Disease Diagnostics.
    Goldberg B; Sichtig H; Geyer C; Ledeboer N; Weinstock GM
    mBio; 2015 Dec; 6(6):e01888-15. PubMed ID: 26646014
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The future of high speed molecular biology in medicine.
    Pattison ST; Reeve AE
    N Z Med J; 2001 Feb; 114(1126):70-2. PubMed ID: 11280430
    [No Abstract]   [Full Text] [Related]  

  • 59. Development and Characterization of Reference Materials for Genetic Testing: Focus on Public Partnerships.
    Kalman LV; Datta V; Williams M; Zook JM; Salit ML; Han JY
    Ann Lab Med; 2016 Nov; 36(6):513-20. PubMed ID: 27578503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current and emerging techniques for diagnostic mutation detection: an overview of methods for mutation detection.
    Taylor CF; Taylor GR
    Methods Mol Med; 2004; 92():9-44. PubMed ID: 14733305
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.